Atlas Trials

Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer

Clinical trial NCT01963182 · COMPLETED

Trial details

NCT number
NCT01963182
Sponsor
Centre Jean Perrin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
First Line Metastatic Colorectal Cancer
Start date
2013-10-01
Primary completion
2019-12-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.